Inflammatory events in hippocampal slice cultures prime neuronal susceptibility to excitotoxic injury: a crucial role of P2X7 receptor-mediated IL-1beta release

J Neurochem. 2008 Jul;106(1):271-80. doi: 10.1111/j.1471-4159.2008.05387.x. Epub 2008 Jul 1.

Abstract

We investigated the consequences of transient application of specific stimuli mimicking inflammation to hippocampal tissue on microglia activation and neuronal cell vulnerability to a subsequent excitotoxic insult. Two-week-old organotypic hippocampal slice cultures, from 7-day-old C57BL/6 donor mice, were exposed for 3 h to lipopolysaccharide (LPS; 10 ng/mL) followed by 3 h co-incubation with 1 mM ATP, or 100 microM 2'3'-O-(4-benzoyl-benzoyl) adenosine 5'-triphosphate triethylammonium, a selective P2X(7) receptor agonist. These treatments in combination, but not individually, induced a pronounced activation and apoptotic-like death of macrophage antigen-1 (MAC-1)-positive microglia associated with a massive release of interleukin (IL)-1beta exceeding that induced by LPS alone. Antagonists of P2X(7) receptors prevented these effects. Transient pre-exposure of slice cultures to a combination of LPS and P2X(7) receptor agonists, but not either one or the other alone, significantly exacerbated CA3 pyramidal cell loss induced by subsequent 12 h exposure to 8 microM alpha-amino-3-hydroxy-5-methyl-4-isoxazole propinate (AMPA). Potentiation of AMPA toxicity was prevented when IL-1beta production or its receptor signaling were blocked by an inhibitor of interleukin-converting-enzyme or IL-1 receptor antagonist during application of LPS + ATP. The same treatments did not prevent microglia apoptosis-like death. These findings show that transient exposure to specific pro-inflammatory stimuli in brain tissue can prime neuronal susceptibility to a subsequent excitotoxic insult. P2X(7) receptor stimulation, and the consequent IL-1beta release, is mandatory for exacerbation of neuronal loss. These mechanisms may contribute to determine cell death/survival in acute and chronic neurodegenerative conditions associated with inflammatory events.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / analogs & derivatives
  • Adenosine Triphosphate / pharmacology
  • Animals
  • Apoptosis / drug effects
  • Apoptosis / physiology
  • Drug Synergism
  • Encephalitis / immunology
  • Encephalitis / metabolism*
  • Encephalitis / physiopathology
  • Excitatory Amino Acid Agonists / pharmacology
  • Hippocampus / immunology
  • Hippocampus / metabolism*
  • Hippocampus / physiopathology
  • Interleukin 1 Receptor Antagonist Protein / pharmacology
  • Interleukin-1beta / drug effects
  • Interleukin-1beta / immunology
  • Interleukin-1beta / metabolism*
  • Lipopolysaccharides / toxicity
  • Mice
  • Mice, Inbred C57BL
  • Microglia / drug effects
  • Microglia / metabolism
  • Nerve Degeneration / chemically induced
  • Nerve Degeneration / immunology
  • Nerve Degeneration / metabolism*
  • Neurotoxins / toxicity*
  • Organ Culture Techniques
  • Pyramidal Cells / drug effects
  • Pyramidal Cells / metabolism
  • Pyramidal Cells / pathology
  • Receptors, Interleukin-1 / antagonists & inhibitors
  • Receptors, Interleukin-1 / metabolism
  • Receptors, Purinergic P2 / drug effects
  • Receptors, Purinergic P2 / immunology
  • Receptors, Purinergic P2 / metabolism*
  • Receptors, Purinergic P2X7

Substances

  • Excitatory Amino Acid Agonists
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1beta
  • Lipopolysaccharides
  • Neurotoxins
  • P2rx7 protein, mouse
  • Receptors, Interleukin-1
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2X7
  • Adenosine Triphosphate